Cargando…
Predictors of lack of serological response to syphilis treatment in HIV-infected subjects
INTRODUCTION: The aim of this study was to determine factors associated with lack of serological response (LSR) to treatment of syphilis among HIV-infected subjects. MATERIALS AND METHODS: Retrospective, longitudinal study on HIV-infected subjects diagnosed and treated for syphilis and with an asses...
Autores principales: | Spagnuolo, Vincenzo, Poli, Andrea, Galli, Laura, Cernuschi, Massimo, Nozza, Silvia, Maillard, Myriam, Gianotti, Nicola, Hasson, Hamid, Bossolasco, Simona, Lazzarin, Adriano, Castagna, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224790/ https://www.ncbi.nlm.nih.gov/pubmed/25394158 http://dx.doi.org/10.7448/IAS.17.4.19654 |
Ejemplares similares
-
Incidence and Predictors of Serological Treatment Response in Early and Late Syphilis Among People Living With HIV
por: Spagnuolo, Vincenzo, et al.
Publicado: (2018) -
Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy
por: Gianotti, Nicola, et al.
Publicado: (2015) -
Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression
por: Carbone, Alessia, et al.
Publicado: (2014) -
Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2014) -
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice
por: Ranzenigo, Martina, et al.
Publicado: (2022)